Simpson Thacher represented Yunfeng Capital Limited in the formation of its second China-focused private equity fund, Yunfeng Fund II, L.P. (“Fund II”). With over $1 billion in capital commitments , Fund II held its final close in May 2014. Fund II will focus primarily on companies in the telecommunications, technology and media, consumer products and healthcare industry. Yunfeng was founded by David Feng Yu (founder of Target Media) and Jack Yun Ma (founder of Alibaba).
More >>
Clyde & Co has advised the Guinean government on the Simandou South iron ore mining project Investment Framework which was signed with Rio Tinto, Chinalco and The International Finance Corporation, a member of the World Bank, in Conakry, the Guinean capital, on 26 May 2014. The next step is the finalisation of the Bankable Feasibility Study in early 2015.
Tags: Clyde & Co LLP
Shearman & Sterling advised Morgan Stanley Senior Funding, Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Goldman Sachs Bank USA, Jefferies Finance LLC and Deutsche Bank Securities Inc. as joint lead arrangers and joint bookrunners in connection with a $1.85 billion refinancing, including a $1.4 billion seven-year first-lien term loan, a €250 million seven-year first-lien term loan and a $200 million five-year revolving credit facility for Catalent Pharma Solutions, Inc.
Tags: Shearman & Sterling LLPThe Firm recently represented Brazilian food producer BRF S.A. in an offering of US$750 million aggregate principal amount of 4.75% Senior Notes due 2024. The offering was conducted in reliance upon Rule 144A and Regulation S under the U.S. Securities Act of 1933.
More >>
Law firm Eversheds has advised Worcestershire County Council and Herefordshire Council on the variation of their £926 million waste PPP by which the councils will fund the procurement by Mercia of a 200,000 tonne per annum, energy from waste plant.
Tags: Eversheds Sutherland
Agile Therapeutics, Inc., a women’s health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced the pricing of its initial public offering of 9,166,667 shares of its common stock at a public offering price of $6.00 per share. Agile Therapeutics has granted the underwriters a 30-day option to purchase up to an aggregate of 1,375,000 additional shares of common stock at the initial public offering price to cover any over-allotments. The shares are expected to begin trading on the NASDAQ Global Market, beginning on May 23, 2014, under the symbol “AGRX.” The offering is expected to close on May 29, 2014, subject to customary closing conditions.
Tags: Morgan, Lewis & Bockius LLP
Paul Hastings LLP, a leading global law firm, announced today that it represented UBS AG, Stamford Branch and RBC Capital Markets as lead arrangers on the financing for the acquisition by The SI Organization, Inc., a portfolio company of Veritas Capital Fund Management, L.L.C. of QinetiQ North America, Inc., a global provider of defense and security technology solutions. The financing consisted of a $478 million first lien term and revolving credit facilities and a $115 million second lien term facility.
More >>
Ropes & Gray represented Metalmark Capital LLC in its sale of wound care services provider Healogics Inc. to Clayton, Dubilier & Rice for $910 million. Jacksonville, Fla.-based Healogics is a market leader in wound care, operating nearly one-third of all hospital outpatient wound care centers in the United States. Additional terms of the transaction, which was announced May 21, were not disclosed.
More >>
